Ebit Alterar Data
AbbVie USD 5.81B 4.36B 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12
Zoetis USD 835M 140M 2025-12